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logical data sets to development of health risk estimates and 
safe exposure levels in the absence of adequate understand-
ing of biological mechanisms of toxicity and dose-response 
behaviour are illustrated and appropriate limits for occupa-
tional and ambient air quality in South Africa are proposed 
based on latest scientific knowledge.
2. Formaldehyde as an air pollutant
Formaldehyde is the most common naturally occurring 
aldehyde in the environment. It is an essential metabolic 
intermediate in all cells, both human and animal, and is 
produced endogenously. Formaldehyde is, however, also 
generated by a range of anthropogenic sources including 
automotive exhaust, cigarette smoke and various products 
containing formaldehyde-based resins and glues used in the 
manufacture of particle board and plywood.
Occupational exposures occur in a wide variety of settings 
and industries which can be summarised into three main 
circumstances, namely (i) production of aqueous formalde-
hyde (formalin) and its use in chemical industry (eg resins, 
preservative etc.), (ii) in relation to its release from formalde-
hyde-based resins in which it is present as a residual and/or 
through the hydrolysis and decomposition by heat namely 
during manufacture of wood products, textiles, synthetic 
vitreous insulation and plastics, and (iii) in relation to the 
pyrolysis or combustion of organic matter, namely engine 
exhaust gases or during fire fighting.
Environmental, or non-occupational, exposures to airborne 
formaldehyde, range from around 0.5 ug/m3, which 
represents the mean natural background concentration 
(WHO, 2001) to up to 100 ug/m3 as short term peak levels 
recorded in heavy traffic or during severe inversions in urban 
environments. The levels of formaldehyde in indoor air are 
often higher than those in outdoor air due to a variety of 
anthropogenic sources, notably offgassing of urea-formal-
dehyde foam insulation, particle board and formaldehyde-
based resins. Mean levels in homes with no urea-formalde-
hyde foam insulation range from 25 to 60 ug/m3 whereas 
levels in mobile homes have been recorded over 100 ug/m3 
(IARC, 1995).
Formaldehyde is formed in the troposphere by photochemi-
cal oxidation of many types of organic compounds from 
both natural and anthropogenic sources. Given the diversity 
and abundance of formaldehyde precursors in urban air, 
secondary atmospheric formation frequently exceeds direct 
emissions from combustion sources, especially during pho-
tochemical air pollution episodes.
Formaldehyde is not a persistent air pollutant being highly 
reactive with photochemicaly generated hydroxyl radicals, 
undergoing direct photolysis, as well as rapid hydrolysis on 
contact with water vapour. Atmospheric half-life is strongly 
dependent on intensity of sunlight, temperature and hu-
midity/moisture content but is no longer than a few hours 
to days in most climatic conditions.
As a ubiquitous air pollutant in both indoor and outdoor air 
the potential adverse health effects from formaldehyde 
exposure have been subject to numerous critical public 
health reviews by regulatory agencies. Public health adviso-
ries have, however, been based primarily on the linear 
extrapolation of dose-response data from occupational 
studies where repeated elevated levels of exposure have led 
to both respiratory irritation and sensitisation as well as 
probable increased incidences of nasopharyngeal cancers.
In this paper the inadequacies in the interpretation of 
occupationally derived dose-response relationships to derive 
safe levels for public exposure to a key HAP in the absence 
of a detailed understanding of dose-response mechanisms 
are explored. Issues around the 2004 IARC reclassification of 
formaldehyde as Class 1 ‘carcinogenic to humans’ are 
discussed and the technical background as to why public 
cancer incidence rates from formaldehyde exposure have 
historically been overestimated by a number of international 
regulatory agencies. The latest knowledge of formaldehyde 
toxicology and carcinogenesis is discussed to illustrate the 
limitations in simple linear extrapolation of occupational data 
to derive cancer risk estimates and safe exposure limits for 
assessment of ambient air quality monitoring data and 
public health risk assessment. Occupational and ambient 
limits for formaldehyde in South Africa are tabled for review 
and debate.
Keywords: HAPs, formaldehyde toxicology, 
dose-response models, occupational versus 
environmental health risk assessment.
1. Introduction
Formaldehyde is a ubiquitous air pollutant that has been 
the focus of significant scientific inquiry and regulatory 
debate over the last decade. Inconclusive or conflict-
ing epidemiological studies coupled with incorrect risk 
estimates from doseresponse models have led to signifi-
cant confusion and misrepresentation of the risk profile of 
formaldehyde both in terms of occupational and public 
health management.
In this paper the key issues and current state of knowl-
edge of formaldehyde toxicology are discussed within the 
context of assessing health risks from both occupational 
and environmental exposures. The limitations of applying 
statistically based dose-response extrapolations to toxico-
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3. Health effects from formaldehyde   
exposure
Most formaldehyde exposures occur by inhalation or 
by skin/eye contact. Due to its rapid solubility in water, 
exposure to formaldehyde vapours produces local irritation 
in mucous membranes including eyes, nose, throat and 
upper respiratory tract.
Low-dose acute exposures can result in headache, rhinitis, 
and dyspnea whilst higher doses may cause severe mucous 
membrane irritation, burning and lacrimation, and lower 
respiratory effects such as bronchitis, pulmonary oedema 
or pneumonia. Dermal irritation and burns can occur, with 
potential for contact dermatitis in sensitized individuals. 
The exact mechanism of action of toxicity is not clear, but it 
is known that it can interact with molecules on cell mem-
branes and in body tissues and fluids and disrupt cellular 
functions (WHO, 2001). The levels at which adverse/irritant 
effects are observed are summarised in Table 1.
In terms of chronic exposures the major concerns associ-
ated with repeated formaldehyde exposure are sensitiza-
tion and cancer. In sensitised individuals, formaldehyde can 
cause asthma and contact dermatitis.
There is sufficient evidence from experimental animals 
and in vitro test systems to demonstrate carcinogenic and 
genetoxic effects from formaldehyde (Inchem, 2002). 
Development of nasal carcinomas in rats exposed to form-
aldehyde vapours has been demonstrated. DNA protein 
cross-links, chromosomal aberrations (CA), sister chromatid 
exchange (SCE) and gene mutation have all been demon-
strated in humans cells in vitro. The frequencies of CA, SCE 
and micronuclei
in peripheral blood lymphocytes have been demonstrated 
to have been affected in studies among workers exposed 
to formaldehyde (Shaham, 2007). The available evidence 
clearly demonstrates that there exists the potential for 
formaldehyde to be a possible human carcinogen. How-
ever, epidemiological evidence for a causal association be-
tween formaldehyde exposure and upper respiratory tract 
cancers in humans is limited or conflicting and the matter 
remains at this time the subject of significant scientific and 
regulatory policy debate as discussed below.
4. Hazard Classification and Carcinogenicity
In terms of managing the risks associated with hazardous 
chemicals, hazard classification, which serves to define 
whether under any defined circumstances, a substance 
could result in a one or more adverse health effects, such 
as for example cancer, is based primarily on a weight-of- 
evidence approach.
In June 2004 the International Agency for Research on 
Cancer (IARC) changed its hazard classification for formal-
dehyde from a “probable” to “known” human carcinogen.
At the time of the IARC change in classification, most 
other regulatory bodies and agencies such as the EU, 
USEPA, NIOSH, and ACGIH still regarded formaldehyde as 
a probable or possible human carcinogen based on suf-
ficient data in animals but limited or conflicting evidence 
in humans. The IARC reclassification rather than prompting 
a shift to more stringent classification by other regulatory 
bodies, initiated more intense review and evaluation of 
existing cohort data sets. This re-analysis of the data has 
led to questions in terms of appropriate hazard classifica-
tion for formaldehyde as well as a re-interpretation of the 
dose-response relationship and risk estimates as detailed 
later in this paper.
The IARC re-classification was based on the decision that 
a statistically significant excess of deaths from NPC in work-
ers exposed to formaldehyde had been demonstrated in 
comparison to the US national population, with statistically 
significant exposure-response relationships for peak and 
cumulative exposures (IARC 2006).
The IARC decision has, however, been challenged (Marsh 
et el 2005, Marsh et al 2007, Bosetti et al 2007) as it was 
deemed to have been based primarily on the results re-
ported by Hauptmann et al (2003; 2004) from an updated 
1994 follow-up of the National Cancer Institute’s (NCI) 
cohort mortality study of workers exposed to formaldehyde 
(Blair et al., 1986; Blair et al., 1990).
The 2003 Hauptmann et al report, which focused on lym-
phohematopoietic malignancies, included an indication of 
a causal association between formaldehyde exposure and 
mortality from leukaemia, particularly myeloid leukaemia. 
The association was immediately questioned on grounds 
of biological implausibility and the methods applied to the 
exposure assessment and statistical analysis (Casanova et al 
2004). The 2004 Hauptmann et al report, which focused 
on solid tumors suggested a possible causal association be-
tween formaldehyde exposure and cancer of the nasophar-
ynx (NPC). As with leukaemia, the NCI exposure-response 
findings for formaldehyde and NPC were based exclusively 
on internal mortality rate comparisons and statistically sig-
nificant exposure-response relationships were observed for 
only two of four formaldehyde exposure metrics consid-
ered, namely peak and cumulative formaldehyde exposure. 
More importantly, the majority of the NPCs examined in 
the NCI cohort were observed in one plant.
The above nothwithstanding, the IARC judgement on 
Hauptmann et al (2004) was that (i) the estimated dose-
response relationships were quite certain, (ii) that it is 
improbable that that all of the positive findings for NPC 
Concentration  
(mg/m3)
Exposure Time Health effects in 
general population
0.18 Repeat exposure Odour deflection 
threshold (50th 
percentble)
0.1 to 3.1 Single or repeated Throat and nose 
irritation threshold
0.6 -1.2 Single or repeated Eye irritation threshold
0.5-2 3-5 hours Decreased nasal 
mucous flow
5-6.2 30 minutes Tolerable for 30 
minutes with 
lacrymation
12-25 1 hour Strong lacrymation
37-50 - Pulmonary oedema, 
pneumonia, danger 
to life
Table 1 – Summary of 
levels at which adverse 
health effects are 
observed (after WHO, 
2001)
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considered, namely peak and cumulative formaldehyde exposure. More importantly, the 
majority of the NPCs examined in the NCI cohort were observed in one plant.
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reported in epidemiological studies could be explained by 
bias or unrecognised confounding effects, and (iii) that the 
results could be generalised to other settings with formal-
dehyde exposure. Hence the IARC decision to reclassifica-
tion formaldehyde.
However, subsequent reanalysis of the NCI cohort data by 
Marsh & Youk (2005), indicated that the data does not 
support the causal association between formaldehyde ex-
posure and NPC as suggested by Hauptmann et al. (2004). 
More specifically, sensitivity analysis demonstrated consid-
erable uncertainty in the exposure-response relationships, 
and that the NPC mortality excesses observed in the one 
plant reported in the NCI data were not associated with 
formaldehyde but rather may reflect the influence of non-
occupational risk factors.
In a comprehensive review of cancer in industry workers 
and professionals exposed to formaldehyde as detailed in 
cohort studies up to 2006, Bosetti et al (2007), reported 
no appreciable excess risk for oral and pharyngeal, sinona-
sal or lung cancers. Bosetti et al (2007) acknowledged the 
non-significantly increased relative risk for nasopharyngeal 
cancer among industry workers attributable to a cluster of 
deaths in a single plant as detailed in the NCI cohort data 
set but concluded insufficient evidence to support a casual 
association between formaldehyde exposure and NPC.
On the basis of the re-evaluation of available cohort data, 
Marsh et al (2007) have suggested that the IARC deci-
sion to classify formaldehyde as Group 1 (known human 
carcinogen) should be reconsidered. No formal response 
has been issued by the IARC at this time.
5. Dose–Reponse Relationships
The US EPA Integrated Risk Information System (IRIS) lists 
an inhalation unit risk for formaldehyde of 1.3 x 10-5 
per ug/m3. This unit risk estimation results in a predicted 
increased risk of developing cancer of 1 in 10,000 from 
inhalation exposure to formaldehyde at levels of approxi-
mately 0.008 mg/m3. Comparison of this level against 
the levels reported earlier in this paper for urban outdoor 
air and workplace and home indoor air concentrations 
indicates that in terms of this risk factor, cancer incidences 
from formaldehyde in the general population would be 
predicted to be greater than 1 in 10,000 to 1 in 1,000. 
Cancer incidences for formaldehyde exposure from mobile 
home indoor air would be predicted to be greater than 
1 in 100. These incidences are not supported by epide-
miological data for NPC which is rare in most populations 
world wide with incidences per 100,000 of between 2 
in USA white males aged 60 to 65 and 50 in Hong Kong 
chinese males of similar age group (Adami, 2007).
The US EPA inhalation risk was based on a simple linear ex-
trapolation of a dose-response curve defined from a study 
by Kerns et al (1983) on rats and, despite the clear lack of 
congruence between risk model predictions and epidemio-
logical data, a revision has not been formally issued since 
its release in 1987. 
In 1991 the US EPA reevaluated its risk assessment for 
formaldehyde and calculated two revised risk estimates 
based on a linear risk estimation procedure but incorporat-
ing information on delivered dose. These estimates were 
between 6 and 50 times lower than the original 1987 
estimates but were never finalised by the US EPA.
The significant over estimations in formaldehyde cancer 
risks for formaldehyde exposure by the US EPA stems 
from use of inappropriate risk assessment methods and 
dose-response projections. Dose-response relationships for 
carcinogenic compounds have traditionally been treated 
as non-threshold responses with extrapolations being 
made from relatively high dose-response data available 
from occupational type settings to very low level exposures 
applicable to public health settings. A detailed study of 
formaldehyde toxicological, mechanistic and dosimetric 
data was undertaken by the Chemical Industry Institute of 
Technology (CIIT) that evaluated dose-response relation-
ships and risk estimation models for formaldehyde based 
on over 20 years of research data (CIIT, 1999; Conolly, 
2004).
The CIIT analysis replaced conservative assumptions based 
on linear extrapolations and a simple non-threshold model 
for carcinogenic compounds with a biologically-based 
approach that recognises that for chemicals such as 
formaldehyde, which humans are exposed to low levels 
on a daily basis as part of normal cellular metabolism 
and that forms a normal component of metabolism with 
multiple pathways existing for its conversion, “standard” 
risk-assessment methods result in incorrect projections 
of the dose-response curve. According to Conolly (2004) 
the fundamental shift in approach relates to recognising 
the presence of a cytotoxicity threshold for formaldehyde 
in the range 0.6 to 1 ppm that represents a de minimis 
(negligible risk of 10-6 or less) in terms of cancer risk as-
sociated with inhalation exposures.
In terms of dose-response relationships, the evidence of 
a cytoxicity threshold means that statistically based linear 
extrapolations of the doseresponse data to low exposure 
levels are invalid, and non-threshold approaches to form-
aldehyde risk modelling are not supported by available 
scientific evidence. The available information demonstrates 
that formaldehyde exposure only poses a carcinogenic 
hazard under conditions that both induce toxicity and 
cause sustained regenerative proliferation.
The CIIT model has been subjected to peer review by both 
the US EPA and Health Canada, with both regulatory 
agencies agreeing that the model provided a significant 
improvement over default approaches adopted in previous 
assessments.
Whilst the US EPA has not withdrawn their original risk 
estimate from the IRIS database, a notice has been issued 
with a revised estimate for inhalation unit risk of 5.5 x 
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10-9 per ug/m3. This revised risk estimate is orders of 
magnitude below the original estimate of 1987, and 
reflects the limitations of linear dose-response extrapola-
tions made in the absence of supporting test data and 
inadequate knowledge of mechanistic toxicity behind the 
dose-response relationship. As of 2008 the US EPA is cur-
rently preparing an updated toxicological review and IRIS 
summary for formaldehyde that is due to be issued before 
the end of the year.
6. Implications for occupational and environmental 
risk management
From a public perspective, the current regulatory 
guidance on assessment and management of health risks 
associated with formaldehyde inhalation exposures must 
appear confusing and contradictory. The reclassification 
of formaldehyde by IARC to Group 1 in 2004 suggests 
that more stringent levels of control and management of 
formaldehyde as a hazardous substance are imperative 
and need to be implemented. None of the other key 
regulatory agencies have however reclassified the hazard 
status of formaldehyde pending further clarity from the 
scientific community in respect of epidemiological data.
In contrast to the IARC reclassification, the reanalysis 
of dose-response relationships and biologically-based 
approach to risk estimations, indicates that the risks from 
exposure to formaldehyde is substantially lower than 
previously estimated, with the risks to the general public 
from average environmental exposure levels are negligible. 
Hazard classification and unit risk estimations represent 
two different components of risk assessment and 
management and despite first appearances, the current 
position is not contradictory
From an occupational health risk management 
perspective, the recognition of a cytotoxic threshold for 
carcinogenic response represents an important point of 
departure and de minimis level for regulation of worker 
exposures. Internationally, there remains a wide range in 
occupational limits set from 0.02 mg/m3 (NIOSH) to 2.5 
mg/m3 (UK) with the trend being to reduce 8 hour TWA’s 
to below the lower limit cytotoxic threshold value of 0.7 
mg/m3.
The South African OHS Act TWA-OEL is currently the 
same as the UK at 2.5 mg/m3 and also requires revision 
in line with current scientific knowledge. The EU Scientific 
Committee on Occupational Exposure Limits (SCOEL) has 
proposed an 8 hour TWA of 0.25 mg/m3, which is an or-
der of magnitude lower and is under consideration for EU 
member states that have limits above this level. A similar 
proposal for revision to the UK limits is being considered 
based on the SCOEL recommendations. 
In terms of setting ambient air quality limits, the WHO 
(2001) has recommended an air quality guideline of 0.1 
mg/m3 as a 30 minute average for protection of general 
population. This is well below the lower limit for cytotoxic 
damage and potential carcinogenic risk but takes into 
account the need for protection against sensory irritant ef-
fects for which a NAOEL of 0.5 mg/m3 has been reported 
(Triebig et al, 2007).
On the basis of current scientific knowledge of form-
aldehyde toxicity and dose-response relationships, it is 
proposed that an appropriate South Africa limit for oc-
cupational exposures would be 0.7 mg/m3  
(8-hr TWA), with recognition that the international trend 
is to reduce limits to 0.3 ppm (0.37 mg/m3), and that the 
guideline for ambient air quality should be set at a level of 
0.1mg/m3. 
